UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prediction of lung cancer patients’ response to combined chemo-radiotherapy using a personalized hybrid model

Mathematica Applicanda, 2019-11, Vol.47 (2)

2019

Volltextzugriff (PDF)

Pretreatment plasma osteopontin level as a marker of response to curative radiotherapy and hormonal treatment for prostate cancer

Radiotherapy and oncology, 2024-11, Vol.200, p.110518, Article 110518

2024

Volltextzugriff (PDF)

Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet

PLoS computational biology, 2020-10, Vol.16 (10), p.e1008234

2020

Volltextzugriff (PDF)

Systemic treatment in patients with malignant pleural mesothelioma - real life experience

BMC cancer, 2022-04, Vol.22 (1), p.432-432, Article 432

2022

Volltextzugriff (PDF)

Polymorphisms in EGFR Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy

International journal of molecular sciences, 2021-05, Vol.22 (11), p.5605

2021

Volltextzugriff (PDF)

Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer

BMC cancer, 2019-05, Vol.19 (1), p.427-12, Article 427

2019

Volltextzugriff (PDF)

Detection of circulating HPV16 DNA as a biomarker in the blood of patients with human papillomavirus‐positive oropharyngeal squamous cell carcinoma

Head & neck, 2019-03, Vol.41 (3), p.632-641

2019

Volltextzugriff (PDF)

Significance of HPV16 Viral Load Testing in Anal Cancer

Pathology oncology research, 2020-10, Vol.26 (4), p.2191-2199

2020

Volltextzugriff (PDF)

Common Variants in Osteopontin and CD44 Genes as Predictors of Treatment Outcome in Radiotherapy and Chemoradiotherapy for Non-Small Cell Lung Cancer

Cells (Basel, Switzerland), 2023-11, Vol.12 (23), p.2721

2023

Volltextzugriff (PDF)

Circulating HPV16 DNA in Blood Plasma as Prognosticator and Early Indicator of Cancer Recurrence in Radio-Chemotherapy for Anal Cancer

Cancers, 2023-01, Vol.15 (3), p.867

2023

Volltextzugriff (PDF)

Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost

Strahlentherapie und Onkologie, 2024-06

2024

Volltextzugriff (PDF)

Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma

The Journal of dermatological treatment, 2022-05, Vol.33 (4), p.2168-2174

2022

Volltextzugriff (PDF)

Quantitative analysis of plasma DNA in anal cancer patients

Contemporary oncology (Poznań, Poland), 2022-01, Vol.26 (2), p.128-132

2022

Volltextzugriff (PDF)

NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay

Genes, 2021-07, Vol.12 (7), p.1080

2021

Volltextzugriff (PDF)

Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment

Melanoma research, 2023-06, Vol.33 (3), p.208-217

2023

Volltextzugriff (PDF)

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy

Contemporary oncology (Poznań, Poland), 2020-01, Vol.24 (1), p.34-41

2020

Volltextzugriff (PDF)

BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma

Melanoma research, 2020-10, Vol.30 (5), p.465-471

2020

Volltextzugriff (PDF)

Combination of immunotherapy and radiotherapy in the treatment of brain metastases from non-small cell lung cancer

Journal of thoracic disease, 2021-05, Vol.13 (5), p.3315-3322

Suwinski, Rafal

2021

Volltextzugriff (PDF)

Tumor regression grading after preoperative hyperfractionated radiotherapy/chemoradiotherapy for locally advanced rectal cancers: interim analysis of phase III clinical study

Neoplasma, 2021-01, Vol.68 (3), p.631-637

2021

Volltextzugriff (PDF)

Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients-Real-World Evidence

Journal of clinical medicine, 2022-04, Vol.11 (8), p.2239

2022

Volltextzugriff (PDF)

Pre-operative hyperfractionated concurrent radiochemotherapy for locally advanced rectal cancers: a phase II clinical study

British journal of radiology, 2017-06, Vol.90 (1074), p.20160731

2017

Volltextzugriff (PDF)

Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients

Melanoma research, 2021-02, Vol.31 (1), p.49-57

2021

Volltextzugriff (PDF)

PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck

PloS one, 2012-03, Vol.7 (3), p.e33396-e33396

2012

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Englisch
(121)
Polnisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(91)
Life Sciences & Biomedicine
(79)
Oncology
(62)
Humans
(53)
Female
(37)
Male
(36)
Middle Aged
(36)
Aged
(30)
Radiology, Nuclear Medicine & Medical Imaging
(29)
Adult
(24)
Radiotherapy
(20)
Patients
(18)
Treatment Outcome
(18)
Chemotherapy
(16)
Tumors
(16)
Lung Cancer
(15)
Metastasis
(15)
Radiation Therapy
(15)
Cancer
(13)
Radiotherapy Dosage
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Prediction of lung cancer patients’ response to combined chemo-radiotherapy using a personalized hybrid model

Pretreatment plasma osteopontin level as a marker of response to curative radiotherapy and hormonal treatment for prostate cancer

Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet

Systemic treatment in patients with malignant pleural mesothelioma - real life experience

Polymorphisms in EGFR Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy

Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer

Detection of circulating HPV16 DNA as a biomarker in the blood of patients with human papillomavirus‐positive oropharyngeal squamous cell carcinoma

Significance of HPV16 Viral Load Testing in Anal Cancer

Common Variants in Osteopontin and CD44 Genes as Predictors of Treatment Outcome in Radiotherapy and Chemoradiotherapy for Non-Small Cell Lung Cancer

Circulating HPV16 DNA in Blood Plasma as Prognosticator and Early Indicator of Cancer Recurrence in Radio-Chemotherapy for Anal Cancer

Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost

Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma

Quantitative analysis of plasma DNA in anal cancer patients

NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients

Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy

BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma

Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy

Combination of immunotherapy and radiotherapy in the treatment of brain metastases from non-small cell lung cancer

Tumor regression grading after preoperative hyperfractionated radiotherapy/chemoradiotherapy for locally advanced rectal cancers: interim analysis of phase III clinical study

Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients-Real-World Evidence

Pre-operative hyperfractionated concurrent radiochemotherapy for locally advanced rectal cancers: a phase II clinical study

Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients

PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck

Suchergebnisse filtern